Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-128667
Filing Date
2021-10-21
Accepted
2021-10-21 21:19:02
Documents
2
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130785-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2130785-4_3seq1.xml 3 2499
2 EXHIBIT 24 tm2130785d4_ex24.htm EX-24 8448
  Complete submission text file 0001104659-21-128667.txt   12314
Mailing Address C/O NYSE EURONEXT 11 WALL STREET NEW YORK NY 10005
Business Address
LEIBOWITZ LAWRENCE E (Reporting) CIK: 0001276505 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40949 | Film No.: 211338520

Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software